Neuberger Berman Group Portfolio holdings
AUM
$130B
This Quarter Return
+11.66%
1 Year Return
+22.03%
3 Year Return
+86.29%
5 Year Return
+159.6%
10 Year Return
+388.21%
AUM
$115B
AUM Growth
+$115B
(+4.5%)
Cap. Flow
-$6.12B
Cap. Flow
% of AUM
-5.34%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,952
New
139
Increased
711
Reduced
931
Closed
89
Top Buys
| 1 |
UnitedHealth
UNH
|
$231M |
| 2 |
CVS Health
CVS
|
$187M |
| 3 |
Gilead Sciences
GILD
|
$179M |
| 4 |
Bank of America
BAC
|
$175M |
| 5 |
Public Service Enterprise Group
PEG
|
$157M |
Top Sells
| 1 |
Chevron
CVX
|
$333M |
| 2 |
JPMorgan Chase
JPM
|
$323M |
| 3 |
Advanced Micro Devices
AMD
|
$310M |
| 4 |
Medtronic
MDT
|
$277M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$276M |
Sector Composition
| 1 | Technology | 24.46% |
| 2 | Healthcare | 12.6% |
| 3 | Financials | 12.53% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Mammoth Energy Services
TUSK
$114M
| $45.4K | ﹤0.01% |
+10,188
| New | +$45.4K |
|
1802
SGHC Ltd
SGHC
$5.58B
| $44.2K | ﹤0.01% |
13,957
-2,647
| -16% | -$8.39K |
|
1803
Telefonica
TEF
$30.2B
| $43.4K | ﹤0.01% |
+11,140
| New | +$43.4K |
|
1804
Stem
STEM
$124M
| $41.1K | ﹤0.01% |
+10,603
| New | +$41.1K |
|
1805
Fate Therapeutics
FATE
$119M
| $39.8K | ﹤0.01% |
+10,637
| New | +$39.8K |
|
|
DHC
1806
Diversified Healthcare Trust
DHC
$910M
| $38.4K | ﹤0.01% |
+10,277
| New | +$38.4K |
|
1807
ChargePoint
CHPT
$250M
| $36.4K | ﹤0.01% |
15,554
-355,361
| -96% | -$832K |
|
1808
Century Therapeutics
IPSC
$41.1M
| $33.3K | ﹤0.01% |
+10,028
| New | +$33.3K |
|
1809
W&T Offshore
WTI
$276M
| $33.2K | ﹤0.01% |
+10,173
| New | +$33.2K |
|
1810
Coeur Mining
CDE
$8.78B
| $32.9K | ﹤0.01% |
10,104
+51
| +0.5% | +$166 |
|
1811
Olaplex Holdings
OLPX
$947M
| $30.1K | ﹤0.01% |
+11,842
| New | +$30.1K |
|
|
EVA
1812
DELISTED
Enviva Inc.
EVA
| $29.3K | ﹤0.01% |
+29,411
| New | +$29.3K |
|
1813
Cerus
CERS
$243M
| $26.3K | ﹤0.01% |
+12,161
| New | +$26.3K |
|
|
RAIN
1814
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $26.1K | ﹤0.01% |
21,742
+9,530
| +78% | +$11.4K |
|
|
AMRN
1815
Amarin Corp
AMRN
$314M
| $25K | ﹤0.01% |
28,754
| – | – |
|
1816
FuelCell Energy
FCEL
$91.6M
| $24.5K | ﹤0.01% |
+15,320
| New | +$24.5K |
|
1817
P3 Health Partners
PIII
$27M
| $24K | ﹤0.01% |
17,030
| – | – |
|
1818
FibroGen
FGEN
$49.3M
| $23.7K | ﹤0.01% |
26,701
+13,927
| +109% | +$12.3K |
|
1819
Ring Energy
REI
$219M
| $23K | ﹤0.01% |
+15,771
| New | +$23K |
|
1820
Tilray
TLRY
$1.37B
| $23K | ﹤0.01% |
+10,000
| New | +$23K |
|
|
LLAP
1821
DELISTED
Terran Orbital Corporation
LLAP
| $21K | ﹤0.01% |
+18,406
| New | +$21K |
|
1822
Aclaris Therapeutics
ACRS
$216M
| $19.1K | ﹤0.01% |
+18,219
| New | +$19.1K |
|
1823
American Well
AMWL
$109M
| $16.7K | ﹤0.01% |
+11,219
| New | +$16.7K |
|
|
TELL
1824
DELISTED
Tellurian Inc.
TELL
| $15.6K | ﹤0.01% |
20,688
-549
| -3% | -$415 |
|
|
QVCGA
1825
QVC Group, Inc. Series A Common Stock
QVCGA
$83.3M
| $14.2K | ﹤0.01% |
+16,218
| New | +$14.2K |
|